• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗 CD137mAbs 诱导的宿主 CD25+CD4+Foxp3+调节性 T 细胞抑制移植物抗宿主病。

Host CD25+CD4+Foxp3+ regulatory T cells primed by anti-CD137 mAbs inhibit graft-versus-host disease.

机构信息

Biomedical Research Center, Ulsan University Hospital, School of Medicine, University of Ulsan, Korea.

出版信息

Biol Blood Marrow Transplant. 2012 Jan;18(1):44-54. doi: 10.1016/j.bbmt.2011.09.004. Epub 2011 Sep 28.

DOI:10.1016/j.bbmt.2011.09.004
PMID:21958951
Abstract

CD25(+)CD4(+)Foxp3(+) regulatory T cells (Tregs) play a pivotal role in the maintenance of self-tolerance and regulation of immune responses. Previous studies have demonstrated that CD137 signals can promote proliferation and survival of Tregs in vitro. Here, we show that in vivo CD137-induced expansion of Tregs in naive mice was dependent upon IL-2 secreted by memory T cells. Tregs primed by anti-CD137 mAbs had a higher immunosuppressive capacity. Preconditioning with anti-CD137 mAbs significantly inhibited graft-versus-host disease (GVHD) in the C57BL/6 → (C57BL/6 × DBA/2) F1 acute GVHD model. In this disease model, a high proportion of host Tregs remained long-term in the recipient spleen, whereas donor hematopoietic cells replaced other host bone marrow-derived cells. Transient depletion of Tregs before transfer of donor cells completely abrogated the inhibitory effect of anti-CD137 mAbs on GVHD. In addition, adoptive transfer of anti-CD137-primed Tregs ameliorated GVHD. Our results demonstrate that it is possible to enhance the survival and/or the immunosuppressive activity of host Tregs in nonmyeloablative GVHD, and that 1 way of accomplishing this is through the prophylactic use of anti-CD137 mAbs in nonmyeloablative GVHD.

摘要

CD25(+)CD4(+)Foxp3(+) 调节性 T 细胞 (Tregs) 在维持自身耐受和调节免疫反应中发挥着关键作用。先前的研究表明,CD137 信号可以促进体外 Tregs 的增殖和存活。在这里,我们表明在幼稚小鼠中,CD137 诱导的 Tregs 扩增依赖于记忆 T 细胞分泌的 IL-2。通过抗 CD137 mAbs 诱导的 Tregs 具有更高的免疫抑制能力。用抗 CD137 mAbs 预处理可显著抑制 C57BL/6→(C57BL/6×DBA/2)F1 急性移植物抗宿主病 (GVHD) 模型中的 GVHD。在这种疾病模型中,大量宿主 Tregs 在受体脾脏中长期存在,而供体造血细胞取代了其他宿主骨髓来源的细胞。在输注供体细胞之前短暂耗尽 Tregs,完全消除了抗 CD137 mAbs 对 GVHD 的抑制作用。此外,过继转移抗 CD137 诱导的 Tregs 可改善 GVHD。我们的结果表明,有可能增强非清髓性 GVHD 中宿主 Tregs 的存活和/或免疫抑制活性,一种实现这一目标的方法是在非清髓性 GVHD 中预防性使用抗 CD137 mAbs。

相似文献

1
Host CD25+CD4+Foxp3+ regulatory T cells primed by anti-CD137 mAbs inhibit graft-versus-host disease.抗 CD137mAbs 诱导的宿主 CD25+CD4+Foxp3+调节性 T 细胞抑制移植物抗宿主病。
Biol Blood Marrow Transplant. 2012 Jan;18(1):44-54. doi: 10.1016/j.bbmt.2011.09.004. Epub 2011 Sep 28.
2
Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.非淋巴细胞减少宿主中同种异体抗原诱导的CD4 + CD25 + Foxp3 +调节性T细胞对慢性移植物抗宿主病的阻断作用。
J Leukoc Biol. 2007 Nov;82(5):1053-61. doi: 10.1189/jlb.0407227. Epub 2007 Aug 7.
3
Pharmacologic expansion of donor-derived, naturally occurring CD4(+)Foxp3(+) regulatory T cells reduces acute graft-versus-host disease lethality without abrogating the graft-versus-leukemia effect in murine models.药物扩增供体来源的、天然存在的 CD4(+)Foxp3(+)调节性 T 细胞可降低急性移植物抗宿主病的致死率,而不消除小鼠模型中的移植物抗白血病效应。
Biol Blood Marrow Transplant. 2011 Aug;17(8):1154-68. doi: 10.1016/j.bbmt.2010.11.022. Epub 2010 Dec 8.
4
Recipient type-specific engineered regulatory T cells prevent graft-vs-host disease after allogeneic bone marrow transplantation in mice.受体类型特异性工程化调节性T细胞可预防小鼠异基因骨髓移植后的移植物抗宿主病。
Transplant Proc. 2011 Jun;43(5):2041-8. doi: 10.1016/j.transproceed.2011.02.055.
5
Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.过继输注体外扩增的人脐血 CD4+CD25+叉头框蛋白 3+调节性 T 细胞可改善急性移植物抗宿主病,其与小鼠模型中 Treg/Th17 平衡的极化有关。
Transfusion. 2012 Jun;52(6):1333-47. doi: 10.1111/j.1537-2995.2011.03448.x. Epub 2011 Nov 21.
6
Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD).体外扩增的人CD4+CD25+Foxp3+调节性T细胞可预防致死性异种移植物抗宿主病(GVHD)。
Cell Immunol. 2009;258(1):65-71. doi: 10.1016/j.cellimm.2009.03.013. Epub 2009 May 1.
7
Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease.抗CD137单克隆抗体在易患慢性移植物抗宿主病的小鼠中诱导致死性移植物抗宿主病。
Biol Blood Marrow Transplant. 2009 Mar;15(3):306-14. doi: 10.1016/j.bbmt.2008.11.035.
8
Injection of donor-derived OX62+ splenic dendritic cells with anti-CD4 monoclonal antibody generates CD4+CD25+FOXP3+ regulatory T cells that prolong allograft skin survival indefinitely and abrogate production of donor-specific antibodies in a rat model.在大鼠模型中,将供体来源的OX62⁺脾树突状细胞与抗CD4单克隆抗体一起注射,可产生CD4⁺CD25⁺FOXP3⁺调节性T细胞,这些细胞可无限期延长同种异体移植皮肤的存活时间,并消除供体特异性抗体的产生。
Transplant Proc. 2009 Oct;41(8):3363-6. doi: 10.1016/j.transproceed.2009.08.038.
9
Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.体外转化生长因子-β1诱导的CD4+CD25+调节性T细胞可逆转并预防小鼠慢性移植物抗宿主病的狼疮样综合征。
Br J Dermatol. 2008 Jun;158(6):1197-209. doi: 10.1111/j.1365-2133.2008.08555.x. Epub 2008 Apr 10.
10
Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.门静脉注射诱导的耐受中CD4+CD25+Foxp3+调节性T细胞增加。
Surgery. 2009 Jun;145(6):663-74. doi: 10.1016/j.surg.2009.01.016. Epub 2009 Apr 19.

引用本文的文献

1
CD137-expressing regulatory T cells in cancer and autoimmune diseases.癌症和自身免疫性疾病中表达CD137的调节性T细胞。
Mol Ther. 2025 Jan 8;33(1):51-70. doi: 10.1016/j.ymthe.2024.12.010. Epub 2024 Dec 11.
2
Exosomes, MDSCs and Tregs: A new frontier for GVHD prevention and treatment.外泌体、髓系抑制细胞和调节性 T 细胞:GVHD 防治的新前沿。
Front Immunol. 2023 Mar 29;14:1143381. doi: 10.3389/fimmu.2023.1143381. eCollection 2023.
3
Fibroblastic reticular cells mitigate acute GvHD via MHCII-dependent maintenance of regulatory T cells.
纤维母细胞网状细胞通过 MHCII 依赖性调节性 T 细胞的维持来减轻急性 GvHD。
JCI Insight. 2022 Nov 22;7(22):e154250. doi: 10.1172/jci.insight.154250.
4
CD137 deficiency causes immune dysregulation with predisposition to lymphomagenesis.CD137 缺陷导致免疫失调,增加淋巴瘤发生的倾向。
Blood. 2019 Oct 31;134(18):1510-1516. doi: 10.1182/blood.2019000644.
5
The promise of CD4FoxP3 regulatory T-cell manipulation : applications for allogeneic hematopoietic stem cell transplantation.CD4FoxP3 调节性 T 细胞操纵的前景:同种异体造血干细胞移植的应用。
Haematologica. 2019 Jul;104(7):1309-1321. doi: 10.3324/haematol.2018.198838. Epub 2019 Jun 20.
6
CD137+CD154- Expression As a Regulatory T Cell (Treg)-Specific Activation Signature for Identification and Sorting of Stable Human Tregs from Expansion Cultures.CD137+CD154 表达作为调节性 T 细胞(Treg)的特异性激活标志物,用于从扩增培养物中鉴定和分选稳定的人 Tregs。
Front Immunol. 2018 Feb 7;9:199. doi: 10.3389/fimmu.2018.00199. eCollection 2018.
7
The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses.共刺激和共抑制反应中的肿瘤坏死因子受体超家族
Immunity. 2016 May 17;44(5):1005-19. doi: 10.1016/j.immuni.2016.04.019.
8
Antibody- and aptamer-strategies for GvHD prevention.预防移植物抗宿主病的抗体和适配体策略。
J Cell Mol Med. 2015 Jan;19(1):11-20. doi: 10.1111/jcmm.12416. Epub 2014 Oct 29.
9
SA-4-1BBL as a novel adjuvant for the development of therapeutic cancer vaccines.SA-4-1BBL作为开发治疗性癌症疫苗的新型佐剂。
Expert Rev Vaccines. 2014 Mar;13(3):387-98. doi: 10.1586/14760584.2014.880340.
10
Combined TIM-3 blockade and CD137 activation affords the long-term protection in a murine model of ovarian cancer.联合 TIM-3 阻断和 CD137 激活可在卵巢癌小鼠模型中提供长期保护。
J Transl Med. 2013 Sep 17;11:215. doi: 10.1186/1479-5876-11-215.